Anterior capsulotomy for obsessive-compulsive disorder: a review of old and new literature.

AC = anterior capsulotomy DBS = deep brain stimulation GK = Gamma Knife Gamma Knife ICH = intracerebral hemorrhage NMD = neurosurgery for mental disorders OCD = obsessive-compulsive disorder SSRI = selective serotonin reuptake inhibitor Y-BOCS = Yale-Brown Obsessive Compulsive Scale anterior capsulotomy focused ultrasound functional neurosurgery obsessive-compulsive disorder psychosurgery radiofrequency ablation

Journal

Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357

Informations de publication

Date de publication:
11 Oct 2019
Historique:
received: 30 01 2019
accepted: 29 04 2019
pubmed: 12 10 2019
medline: 12 10 2019
entrez: 12 10 2019
Statut: aheadofprint

Résumé

Over the last two decades, deep brain stimulation (DBS) has gained popularity as a treatment of severe and medically refractory obsessive-compulsive disorder (OCD), often using brain targets informed by historical lesional neurosurgical procedures. Paradoxically, the use of DBS in OCD has led some multidisciplinary teams to revisit the use of lesional procedures, especially anterior capsulotomy (AC), although significant aversion still exists toward the use of lesional neurosurgery for psychiatric disorders. This paper aims to review all literature on the use of AC for OCD to examine its effectiveness and safety profile.All publications on AC for OCD were searched. In total 512 patients were identified in 25 publications spanning 1961-2018. In papers where a Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score was available, 73% of patients had a clinical response (i.e., > 35% improvement in Y-BOCS score) and 24% patients went into remission (Y-BOCS score < 8). In the older publications, published when the Y-BOCS was not yet available, 90% of patients were deemed to have had a significant clinical response and 39% of patients were considered symptom free. The rate of serious complications was low.In summary, AC is a safe, well-tolerated, and efficacious therapy. Its underuse is likely a result of historical prejudice rather than lack of clinical effectiveness.

Identifiants

pubmed: 31604328
doi: 10.3171/2019.4.JNS19275
pii: 2019.4.JNS19275
doi:
pii:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-10

Auteurs

Joshua Pepper (J)

1Department of Neurosurgery, Queen Elizabeth Hospital, Birmingham, United Kingdom.

Ludvic Zrinzo (L)

2Unit of Functional Neurosurgery, Queen Square, London, United Kingdom; and.

Marwan Hariz (M)

3Department of Clinical Neuroscience, Umeå University, Umeå, Sweden.

Classifications MeSH